MedPath

Temple University-of the Commonwealth System of Higher Education

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Outpatient Use of Ivermectin in COVID-19

Phase 3
Withdrawn
Conditions
Covid19
Interventions
First Posted Date
2020-08-28
Last Posted Date
2021-05-26
Lead Sponsor
Temple University
Registration Number
NCT04530474
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University Hospital, Philadelphia, Pennsylvania, United States

Pilot HPV Vaccination in Chinese American Community

Not Applicable
Completed
Conditions
HPV
Interventions
Behavioral: General Vaccination Education
Behavioral: Interventional HPV vaccination video modules
First Posted Date
2020-08-10
Last Posted Date
2023-04-13
Lead Sponsor
Temple University
Target Recruit Count
170
Registration Number
NCT04505930
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Center for Asian Health, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States

Smoking Cessation in NYC

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: individualized counselor-led MI sessions
Behavioral: general health education session
Behavioral: NRT
First Posted Date
2020-07-28
Last Posted Date
2023-04-13
Lead Sponsor
Temple University
Target Recruit Count
139
Registration Number
NCT04489524
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Center for Asian Health, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States

Korean CRC Screening Study PT13599

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Behavioral: interactive group education, navigation services and engagement of health care providers for referrals, and linkage to care.
Behavioral: Education Session on General Health
First Posted Date
2020-07-20
Last Posted Date
2023-04-13
Lead Sponsor
Temple University
Target Recruit Count
925
Registration Number
NCT04478110
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Center for Asian Health, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States

RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM

Phase 2
Withdrawn
Conditions
Cytokine Storm
SARS-CoV-2
Interventions
Drug: Placebo
First Posted Date
2020-06-16
Last Posted Date
2021-04-19
Lead Sponsor
Temple University
Registration Number
NCT04433078
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University Hospital, Philadelphia, Pennsylvania, United States

Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid

Phase 1
Completed
Conditions
Cocaine Dependence
Interventions
Other: Placebo
First Posted Date
2020-06-02
Last Posted Date
2023-06-22
Lead Sponsor
Temple University
Target Recruit Count
13
Registration Number
NCT04411914
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University Episcopal Hospital, Philadelphia, Pennsylvania, United States

Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis

Not Applicable
Completed
Conditions
Early Psychosis
Interventions
Behavioral: Decision aid
First Posted Date
2020-05-04
Last Posted Date
2021-02-15
Lead Sponsor
Temple University
Target Recruit Count
18
Registration Number
NCT04373590
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Psychosis Education, Assessment, Care and Empowerment (PEACE), Philadelphia, Pennsylvania, United States

Improving Everyday Task Performance Through Repeated Practice in Virtual Reality.

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Dementia
Dementia, Mild
Dementia, Mixed
Dementia, Vascular
Dementia Alzheimers
Alzheimer Disease
Mild Dementia
Dementia of Alzheimer Type
Interventions
Behavioral: Virtual Kitchen Training
First Posted Date
2020-03-19
Last Posted Date
2024-07-16
Lead Sponsor
Temple University
Target Recruit Count
16
Registration Number
NCT04315337
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University, Philadelphia, Pennsylvania, United States

Feasibility of the SmartPrompt for Improving Everyday Function in Dementia

Not Applicable
Completed
Conditions
Dementia Alzheimers
Dementia, Vascular
Dementia, Mild
Dementia, Mixed
Mild Cognitive Impairment
Dementia
Dementia of Alzheimer Type
Mild Dementia
Interventions
Behavioral: SmartPrompt smartphone application
First Posted Date
2020-03-18
Last Posted Date
2024-07-16
Lead Sponsor
Temple University
Target Recruit Count
20
Registration Number
NCT04313582
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University, Philadelphia, Pennsylvania, United States

Investigation of Eluxadoline for Diabetic Diarrhea

Phase 2
Withdrawn
Conditions
Diabetic Diarrhea
Diarrhea
Diabetes
Interventions
First Posted Date
2020-03-18
Last Posted Date
2023-05-06
Lead Sponsor
Temple University
Registration Number
NCT04313088
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Temple University Hospital, Philadelphia, Pennsylvania, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath